Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,569,202
  • Shares Outstanding, K 227,939
  • Annual Sales, $ 2,348 M
  • Annual Income, $ 128,370 K
  • EBIT $ 106 M
  • EBITDA $ 163 M
  • 60-Month Beta 2.32
  • Price/Sales 2.62
  • Price/Cash Flow 32.25
  • Price/Book 11.34

Options Overview Details

View History
  • Implied Volatility 118.53% (+6.64%)
  • Historical Volatility 133.59%
  • IV Percentile 97%
  • IV Rank 87.15%
  • IV High 127.25% on 05/05/25
  • IV Low 59.38% on 12/31/25
  • Expected Move (DTE 4) 2.86 (9.47%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 285,177
  • Volume Avg (30-Day) 173,056
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 1,057,349
  • Open Int (30-Day) 1,051,402
  • Expected Range 27.40 to 33.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.06
  • Number of Estimates 4
  • High Estimate $0.14
  • Low Estimate $0.00
  • Prior Year $0.20
  • Growth Rate Est. (year over year) -70.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.62 +67.45%
on 03/30/26
31.80 -1.95%
on 04/20/26
+9.16 (+41.60%)
since 03/20/26
3-Month
13.74 +126.93%
on 02/24/26
31.80 -1.95%
on 04/20/26
+0.71 (+2.33%)
since 01/20/26
52-Week
13.74 +126.93%
on 02/24/26
70.43 -55.73%
on 07/31/25
+3.95 (+14.51%)
since 04/17/25

Most Recent Stories

More News
Stocks Settle Higher on Tech Earnings and Ceasefire Optimism

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.26%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.49%. June E-mini...

ALK : 44.22 (-2.60%)
ADI : 382.98 (+3.10%)
GLW : 166.10 (+1.05%)
AMD : 274.88 (-1.26%)
SPY : 707.68 (-0.35%)
ADSK : 244.26 (+0.93%)
ORCL : 175.08 (+0.01%)
DOW : 37.01 (+3.96%)
DKS : 229.47 (+2.28%)
VOYG : 30.61 (-2.24%)
QQQ : 645.34 (-0.54%)
FTNT : 82.49 (+0.79%)
RFK Jr. Just Gave Hims & Hers Stock a Jolt. Should You Chase the Rally Here?

Hims & Hers stock rallies as RFK Jr. says FDA may remove restrictions on certain peptides. But HIMS shares remain unattractive to own in 2026.

HIMS : 30.82 (+6.94%)
AMZN : 246.83 (-1.49%)
Stocks Edge Higher as Chipmakers Rebound

The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.43%. June E-mini S&P futures (ESM26...

ALK : 44.22 (-2.60%)
FLUT : 109.14 (-0.85%)
ADI : 382.98 (+3.10%)
HIMS : 30.82 (+6.94%)
PPG : 114.58 (-0.24%)
FN : 686.72 (-0.46%)
TXN : 232.73 (+1.27%)
$IUXX : 26,496.19 (-0.66%)
ZNM26 : 111-175 (-0.15%)
ABT : 96.59 (-0.23%)
GLW : 166.10 (+1.05%)
ESM26 : 7,136.00 (-0.36%)
Stocks Pressured by Weakness in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.21%. June E-mini S&P futures...

AMAT : 392.35 (-1.16%)
INTU : 397.02 (+0.96%)
FLUT : 109.14 (-0.85%)
HIMS : 30.82 (+6.94%)
PPG : 114.58 (-0.24%)
FN : 686.72 (-0.46%)
$IUXX : 26,496.19 (-0.66%)
ASML : 1,467.45 (+0.52%)
ZNM26 : 111-175 (-0.15%)
ABT : 96.59 (-0.23%)
GLW : 166.10 (+1.05%)
ESM26 : 7,136.00 (-0.36%)
Q4 Earnings Outperformers: Hims & Hers Health (NYSE:HIMS) And The Rest Of The Healthcare Technology Stocks

Q4 Earnings Outperformers: Hims & Hers Health (NYSE:HIMS) And The Rest Of The Healthcare Technology Stocks

HIMS : 30.82 (+6.94%)
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial results after the market closes on Monday,...

HIMS : 30.82 (+6.94%)
2 Profitable Stocks with Exciting Potential and 1 We Ignore

2 Profitable Stocks with Exciting Potential and 1 We Ignore

NESR : 23.92 (-1.52%)
HIMS : 30.82 (+6.94%)
LC : 17.75 (+1.78%)
3 Sectors to Buy While They're Down and 1 to Walk Away From

Jeff Clark and Andy Swan share three beaten-down sectors with contrarian upside and one popular sector to avoid, plus specific stock picks in financials, healthcare, and software.

APO : 125.90 (+1.03%)
NFLX : 93.90 (-3.50%)
GOOGL : 339.08 (-0.76%)
OWL : 9.82 (-0.30%)
FIG : 18.83 (-0.48%)
HIMS : 30.82 (+6.94%)
MOH : 150.88 (+1.28%)
ORCL : 175.08 (+0.01%)
IGV.BZ : N/A (N/A)
MSFT : 418.56 (-1.00%)
KKR : 103.50 (-0.10%)
OSCR : 16.48 (+4.37%)
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC (“KSF”), announces that KSF has commenced an investigation into...

HIMS : 30.82 (+6.94%)
Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?

Wegovy subscriptions may create interest, but there is a major threat looming for Novo Nordisk.

NVO : 40.61 (+0.22%)
HIMS : 30.82 (+6.94%)
LLY : 926.36 (-0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 32.31
2nd Resistance Point 31.05
1st Resistance Point 29.93
Last Price 30.82
1st Support Level 27.55
2nd Support Level 26.29
3rd Support Level 25.17

See More

52-Week High 70.43
Fibonacci 61.8% 48.77
Fibonacci 50% 42.08
Fibonacci 38.2% 35.40
Last Price 30.82
52-Week Low 13.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.